跳至主要内容
临床试验/JPRN-jRCTs031180276
JPRN-jRCTs031180276已完成未知

Pilot study of absolute ethanol injection sclerotherapy for lymphangioma circumscriptum

Fujino Akihiro0 个研究点目标入组 8 人开始时间: 2019年3月14日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
8

研究概览

简要总结

The purpose of this study was to evaluate the efficacy and safety of localized injection therapy with anhydrous ethanol for lymphangioma circumscriptum, which is known as a refractory lesion. The efficacy of the treatment was demonstrated in terms of the percentage of improvement in two parameters: erythema and bulging. No adverse events requiring treatment were observed and there were no safety issues.

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • Any lymphangioma circumscriptum patients requiring treatment who had given us an informed consent to participate in this clinical study

排除标准

  • hypersensitivity to alcohol

研究者

发起方
Fujino Akihiro

相似试验

Absolute ethanol sclerotherapy for lymphangioma... | 临床试验